| Summary |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Reference and Education > Science > What is Molecular Biology |
|
Summary - What is Molecular Biology
Molecular biology is the science of study of biology at the molecular level.
William Astbury in Na According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ture described molecular biology as: "... not so much a technique as an approach, an approach from ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in the viewpoint of the so-called basic sciences with the leading idea of searching below the large-s lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. cale manifestations of classical biology for the corresponding molecular plan. It is concerned part here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe icularly with the forms of biological molecules and ..... is predominantly three-dimensional and st d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ructural - which does not mean, however, that it is merely a refinement of morphology - it must at ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc the same time inquire into genesis and function" (W.T. Astbury, Nature 190, 1124. 1961) Molecular easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi biology has allowed us to uncover the mysteries of the human body, viruses, bacteria and all other nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically life. As such, it has allowed the progress of medicine to advance to such a degree so that we may b and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ egin to cure the previously incurable, and to eventually find cures for every disease that afflicts ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi human kind. Molecular biology depends not only on biology but also chemistry, genetics, and bioche ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a mistry. The understanding of the interactions between DNA, RNA, proteins and lipids is vital in und dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod erstanding how cells work and how diseases affect these interactions. Researchers and scientists ar cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e slowly piecing together these interactions and how each biological molecule functions. By underst tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen anding this, scientists can then examine disease conditions, and see if the function of any of the t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel molecules has changed. If a molecule or interaction is affected by disease, scientists can then cre ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ate therapies which target these alterations and repair them. In conclusion, molecular biology is y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products a vital field in our advancement of medicine and technology. By understanding how biological molecu . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de les interact and function, we will be able to not only gain an appreciation of the workings inside elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the cell, but also it will allow us detect and to fix any problems that arise during disease states tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Your Resume & Job Search Websites, Be Careful With Your Email Address The High Deductible Health Plan - What Is It And How Does It Benefit Me? Cable Vs Satellite TV - 7 Benefits To The Real Deal About Satellite TV Offer
|